Less apoptotic cells in CPZ-treated schizophrenic brain than in control.
Upregulation of TF and Bcl-2 in CPZ-treated schizophrenics.
CPZ treatment increases the levels of Bcl-2 and TF in rat brain.
Over-expression of TF increases Bcl-2 levels in C6 cells.
CPZ inhibits mitochondrial apoptotic pathway by increasing levels of TF.